dpp 4 inhibitors vs glp 1 agonist Mechanism of action for GIP, GLP-1 analogues and DPP4 in GLP-1 Receptor Agonists Have better

This can cause significant uncomfortable side effects like nausea, bloating, and constipation

Designing small molecules able to target multiple receptors might sound difficult, but Septerna says the allosteric binding site it has discovered is even better conserved across all incretin receptors than the site targeted by peptides and other small molecule drugs

P =0.004)

GLP-1 RAs have been found to improve overall cardiovascular health and reduce major adverse cardiovascular events (MACE) by improving the endothelial function of the vasculature and lowering ANP (atrial natriuretic peptide) production, leading to reduced blood pressure

Its shorter duration of action produces pronounced effects on postprandial glucose through delayed gastric emptying